This study identified six BA-related prognostic genes (SERPINB5, CALU, TFRC, LY6D, SFRP1, GBP2) in PAAD through systematic bioinformatics screening and developed a risk assessment model based on these markers, offering a new molecular framework for PAAD prognosis. Here, GBP2 is linked to pancreatic adenocarcinoma.